Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/26/1996WO1996029327A1 Trypsin and thrombin inhibitors
09/26/1996WO1996029326A1 3-benzylamino-2-phenylpiperidines as neurokinin antagonists
09/26/1996WO1996029321A1 10-DEACETYLBACCATINE III AND 10-DEACETYL 14β-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
09/26/1996WO1996029317A1 Aromatic compounds useful as tachykinin antagonists
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029309A1 N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS
09/26/1996WO1996029304A1 Nonpeptides as tachykinin antagonists
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029079A1 Ophthalmological composition comprising activated vitamin d
09/26/1996WO1996029078A1 OVULATION-INHIBITING AGENT FOR HORMONAL CONTRACEPTION CONTAINING BETWEEN 50 AND 70 νg LEVONURGESTREL AND MORE THAN 30 TO 40 νg ETHINYLOESTRADIOL
09/26/1996WO1996029077A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/26/1996WO1996029076A2 Treatment of inflammatory bowel disorders with cotinine
09/26/1996WO1996029075A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/26/1996WO1996029073A1 Nodulisporic acid derivatives
09/26/1996WO1996029072A1 Anthelmintic use of nodulisporic acid and analogs thereof
09/26/1996WO1996029071A1 Uses of antibacterial compounds
09/26/1996WO1996029070A1 Extended stability formulations for paclitaxel
09/26/1996WO1996029069A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996WO1996029068A2 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this
09/26/1996WO1996029067A1 Anti-viral and anti-cancer agents
09/26/1996WO1996029066A1 Prilocaine and hydrofluorocarbon aerosol preparations
09/26/1996WO1996029065A2 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996WO1996029064A1 Oil in water emulsions containing propofol and edetate
09/26/1996WO1996029063A2 Pinitol and derivatives thereof for the treatment of metabolic disorders
09/26/1996WO1996029058A1 Peroral composition for controlled release in the lower gastrointestinal tract
09/26/1996WO1996029056A1 Topically applied pharmaceutical composition, method of preparing it and its use
09/26/1996WO1996029053A1 Transparent rapid-release preparations of non-steroid analgesics
09/26/1996WO1996029052A1 Aerosolized general anesthetic agents
09/26/1996WO1996029050A1 Depigmenting dermatological and/or cosmetic composition
09/26/1996WO1996029045A1 Compositions for the treatment of dandruff
09/26/1996WO1996028975A1 Topical antimicrobial agents
09/26/1996WO1996024373A3 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
09/26/1996WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
09/26/1996WO1996023504A3 Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996022774A3 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
09/26/1996WO1996016651A3 USE OF HALOGENATED β-CARBOLINES AS MODEL SUBSTANCES TO PRODUCE NEURODEGENERATIVE DISORDERS
09/26/1996DE4396528C1 Abalone shell powder and sesame oil compsn for burn treatment
09/26/1996DE19509805A1 Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica Transparent, quick-release formulations of nonsteroidal analgesics
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2215825A1 Stem-loop and circular oligonucleotides
09/26/1996CA2215797A1 Methods for microbial regulation
09/26/1996CA2215731A1 Use of retinoids for the manufacture of a medicament for the treatment of restenosis
09/26/1996CA2215700A1 Aromatic compounds useful as tachykinin antagonists
09/26/1996CA2215699A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents
09/26/1996CA2215696A1 Aerosolized general anesthetic agents
09/26/1996CA2215674A1 Ophthalmic composition containing active vitamin d
09/26/1996CA2215671A1 Aminotetralin derivative for the therapy of cardiovascular diseases
09/26/1996CA2215322A1 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/26/1996CA2215106A1 N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors
09/26/1996CA2214635A1 Pinitol and derivatives thereof for the treatment of metabolic disorders
09/26/1996CA2214107A1 Fucopeptides
09/26/1996CA2213747A1 Peroral composition for controlled release in the lower gastrointestinal tract
09/26/1996CA2211191A1 Nonpeptides as tachykinin antagonists
09/26/1996CA2211179A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733647A2 Polysaccharides and preparation thereof
09/25/1996EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
09/25/1996EP0733635A1 Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation
09/25/1996EP0733634A1 Process for preparing a thieno(2,3-B)(1,5) benzodiazepine derivative
09/25/1996EP0733628A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists
09/25/1996EP0733627A1 Thiophene compounds, a method for their preparation and pharmaceutical compositions containing them
09/25/1996EP0733626A1 N-(Benzofuranazyl)-arylsulphonamides and their analogues useful as endothelin-receptor-antagonists
09/25/1996EP0733621A1 Novel imidazole derivative and process for producing the same
09/25/1996EP0733620A1 Alpha-substituted-1-benzyl-naphthyls
09/25/1996EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells
09/25/1996EP0733372A2 Pharmaceutical base for the formulation of nanosuspensions
09/25/1996EP0733370A1 Antagonistic inhibitor against mesenchymal cell growth
09/25/1996EP0733369A1 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
09/25/1996EP0733368A1 Granule fomulation for olanzapine
09/25/1996EP0733367A1 Oral olanzapine formulation
09/25/1996EP0733365A2 Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer
09/25/1996EP0733364A1 Medicinal composition for circulatory organ
09/25/1996EP0733363A1 Process to prepare free-flowing thioctic acid and its use
09/25/1996EP0733362A1 Polynactins as antiallergic agents and IL-5 inhibitors
09/25/1996EP0733361A2 Method for inactivating enveloped viruses and sperm
09/25/1996EP0733360A2 Use of a combination of arachidonic acid and dosohexaenoic acid in the preparation of e medicament for treating cell membrane abnormalities due to low C20 or C22 essential fatty acids
09/25/1996EP0733359A1 Use of amantadine for the prophylactic treatment of migraine
09/25/1996EP0733358A2 Nanosuspensions for intravenous application
09/25/1996EP0733214A1 Dense microsphere components derived from mammalian brain tissue and antibodies thereto
09/25/1996EP0733110A1 Tuberous sclerosis 2 gene and uses thereof
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733069A1 Purified primate ctla-8 antigens and related reagents
09/25/1996EP0733067A1 N-terminally chemically modified protein compositions and methods
09/25/1996EP0733055A1 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antidegenerative agents
09/25/1996EP0733054A1 Novel quinolone compounds and processes for the preparation thereof
09/25/1996EP0733053A1 Oxathiolanes, method for their preparation and pharmaceutical compositions containing same
09/25/1996EP0733052A1 Bicyclene derivatives, their production and use
09/25/1996EP0733051A1 Bicyclic heterocycles as neurokinin a antagonists
09/25/1996EP0733049A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
09/25/1996EP0733047A1 Novel substituted oxazolidines
09/25/1996EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments
09/25/1996EP0733045A1 4,6-dianilino-pyrimidine derivatives, their preparation and their use as tyrosine kinase inhibitors
09/25/1996EP0733044A1 Compounds
09/25/1996EP0733043A1 Tricyclic derivatives and their use in pharmaceuticals
09/25/1996EP0733041A1 Anthracene spiro-pyrrolidines as immuno-modulators
09/25/1996EP0733040A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
1 ... 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 ... 7860